Skip to content
52
For organizationsPricingSign in

Connections

GSK (Fka Glaxosmithkline Inc.)

13 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.

Start with
and connect to

GSK (Fka Glaxosmithkline Inc.)

Federal lobbying records

Open page
Bills it lobbied on8 of 60
S 1040 Drug Competition Enhancement Act10 reports · On the floor calendarS 1041 Affordable Prescriptions for Patients Act10 reports · Passed one chamberS 1096 Preserve Access to Affordable Generics and Biosimilars Act10 reports · On the floor calendarS 1095 Stop STALLING Act10 reports · On the floor calendarHR 1492 To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program10 reports · In committeeS 708 RESTORE Patent Rights Act of 202510 reports · In committeeS 1097 Interagency Patent Coordination and Improvement Act of 20258 reports · On the floor calendarS 652 Protecting Patients from Deceptive Drug Ads Act8 reports · In committee
Lawmakers it funded or lobbied5 of 44
John CornynLeads 2 of these billsRichard DurbinLeads 2 of these billsAmy KlobucharLeads 2 of these billsChristopher CoonsLeads 1 of these billsGregory MurphyLeads 1 of these bills
GSK (Fka Glaxosmithkline Inc.): 8 of 60 bills it lobbied on and 5 of 44 lawmakers it gave to or whose bills it lobbied on. Point at anyone to see how they are linked.Includes 1 other record under the same name, such as its political action committee and state lobbying filings.

Every link on this map

The same connections as a table, with the reason each one is here.

Connections of GSK (Fka Glaxosmithkline Inc.)
S 1040Bills it lobbied onGSK (Fka Glaxosmithkline Inc.) named S 1040, “Drug Competition Enhancement Act”, in 10 lobbying reports.10 reports
S 1041Bills it lobbied onGSK (Fka Glaxosmithkline Inc.) named S 1041, “Affordable Prescriptions for Patients Act”, in 10 lobbying reports.10 reports
S 1096Bills it lobbied onGSK (Fka Glaxosmithkline Inc.) named S 1096, “Preserve Access to Affordable Generics and Biosimilars Act”, in 10 lobbying reports.10 reports
S 1095Bills it lobbied onGSK (Fka Glaxosmithkline Inc.) named S 1095, “Stop STALLING Act”, in 10 lobbying reports.10 reports
HR 1492Bills it lobbied onGSK (Fka Glaxosmithkline Inc.) named HR 1492, “To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program”, in 10 lobbying reports.10 reports
S 708Bills it lobbied onGSK (Fka Glaxosmithkline Inc.) named S 708, “RESTORE Patent Rights Act of 2025”, in 10 lobbying reports.10 reports
S 1097Bills it lobbied onGSK (Fka Glaxosmithkline Inc.) named S 1097, “Interagency Patent Coordination and Improvement Act of 2025”, in 8 lobbying reports.8 reports
S 652Bills it lobbied onGSK (Fka Glaxosmithkline Inc.) named S 652, “Protecting Patients from Deceptive Drug Ads Act”, in 8 lobbying reports.8 reports
John CornynLawmakers it funded or lobbiedJohn Cornyn leads 2 bills GSK (Fka Glaxosmithkline Inc.) lobbied on.Leads 2 of these bills
Richard DurbinLawmakers it funded or lobbiedRichard Durbin leads 2 bills GSK (Fka Glaxosmithkline Inc.) lobbied on.Leads 2 of these bills
Amy KlobucharLawmakers it funded or lobbiedAmy Klobuchar leads 2 bills GSK (Fka Glaxosmithkline Inc.) lobbied on.Leads 2 of these bills
Christopher CoonsLawmakers it funded or lobbiedChristopher Coons leads 1 bill GSK (Fka Glaxosmithkline Inc.) lobbied on.Leads 1 of these bills
Gregory MurphyLawmakers it funded or lobbiedGregory Murphy leads 1 bill GSK (Fka Glaxosmithkline Inc.) lobbied on.Leads 1 of these bills